<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We determined the concentrations of the putative transmitter amino acids in the cerebrospinal fluid of patients with Alzheimer type <z:hpo ids='HP_0000726'>dementia</z:hpo> (ATD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> of the <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger</z:e> type (VDBT) </plain></SENT>
<SENT sid="1" pm="."><plain>In ATD, <z:chebi fb="0" ids="29995">aspartate</z:chebi> and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentrations were significantly and selectively reduced, while in VDBT, concentrations of <z:chebi fb="0" ids="29995">aspartate</z:chebi>, <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) and many other amino acids were decreased non-selectively </plain></SENT>
<SENT sid="2" pm="."><plain>In both ATD and VDBT, we found a tendency for <z:hpo ids='HP_0000001'>all</z:hpo> amino acids to increase with progression of the disease, and this reached statistical significance for some amino acids </plain></SENT>
</text></document>